Is methotrexate effective in psoriatic arthritis?

被引：0
|
作者：
Philip J. Mease
机构：
[1] Seattle Rheumatology Associates,
[2] Rheumatology Research,undefined
[3] Swedish Medical Center,undefined
来源：
Nature Reviews Rheumatology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Although methotrexate is the most widely used medication for psoriatic arthritis (PsA), evidence for its effectiveness is scant. The recent MIPA trial failed to show disease-modifying effects. Was this outcome due to true inefficacy, or to trial issues? Data on symptom-modulating and disease-modifying effects of methotrexate in PsA are explored.
引用
收藏
页码：251 / 252
页数：1
相关论文
共 50 条
  • [21] COSTS AND BENEFITS OF METHOTREXATE IN PSORIATIC ARTHRITIS
    Deininger, K.
    Maksabedian, E.
    VALUE IN HEALTH, 2020, 23 : S371 - S372
  • [22] Psoriatic arthritis, methotrexate, and liver toxicity
    Alarcón, GS
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (04) : 213 - 214
  • [23] Role of Methotrexate in the Management of Psoriatic Arthritis
    Musaab Elmamoun
    Vinod Chandran
    Drugs, 2018, 78 : 611 - 619
  • [24] Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
    Calasan, Maja Bulatovic
    van den Bosch, Oscar F. C.
    Creemers, Marjonne C. W.
    Custers, Martijn
    Heurkens, Antonius H. M.
    van Woerkom, Jan Maarten
    Wulffraat, Nico M.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [25] Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis
    Lindsey Tilling
    Sue Townsend
    Joel David
    Clinical Drug Investigation, 2006, 26 : 55 - 62
  • [26] Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
    Maja Bulatović Ćalasan
    Oscar FC van den Bosch
    Marjonne CW Creemers
    Martijn Custers
    Antonius HM Heurkens
    Jan Maarten van Woerkom
    Nico M Wulffraat
    Arthritis Research & Therapy, 15
  • [27] Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
    Tilling, L
    Townsend, S
    David, J
    CLINICAL DRUG INVESTIGATION, 2006, 26 (02) : 55 - 62
  • [28] A pharmacogenetic study on the efficacy of methotrexate in psoriatic arthritis
    Chandran, V.
    Siannis, F.
    Schentag, C. T.
    Peddle, L.
    Pellett, F. J.
    Farewell, V.
    Rahman, P.
    Gladman, D. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1410 - 1410
  • [29] Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A
    Gül, Ü
    Gönül, M
    Kiliç, A
    Erdem, R
    Çakmak, SK
    Gündüz, H
    CLINICAL THERAPEUTICS, 2006, 28 (02) : 251 - 254
  • [30] Longterm therapy of psoriatic arthritis with gold or methotrexate
    Lacaille, D
    Stein, HB
    Klinkhoff, AV
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1367 - 1367
12345